Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,786,000 | 1,121,000 | 1,139,000 | 1,342,000 | 2,595,000 |
| Marketable Securities | 10,437,000 | 8,525,000 | 17,694,000 | 18,650,000 | 15,255,000 |
| Receivables | 7,913,000 | 6,772,000 | 8,025,000 | 8,221,000 | 8,225,000 |
| Inventories | 8,020,000 | 7,068,000 | 7,508,000 | 7,578,000 | 6,783,000 |
| Income taxes - deferred | 3,264,000 | 2,736,000 | 3,374,000 | N/A | N/A |
| Other current assets | 3,647,000 | 6,581,000 | 12,186,000 | 5,350,000 | 6,091,000 |
| TOTAL | $35,067,000 | $32,803,000 | $49,926,000 | $41,141,000 | $38,949,000 |
| Non-Current Assets | |||||
| PPE Net | 13,745,000 | 12,969,000 | 13,385,000 | 13,865,000 | 13,318,000 |
| Investments And Advances | 20,262,000 | 20,147,000 | 2,767,000 | 7,015,000 | 7,116,000 |
| Intangibles | 77,893,000 | 82,138,000 | 88,622,000 | 104,693,000 | 107,097,000 |
| Other Non-Current Assets | 7,262,000 | 19,537,000 | 4,723,000 | 5,082,000 | 5,135,000 |
| TOTAL | $119,162,000 | $134,791,000 | $109,497,000 | $130,655,000 | $132,666,000 |
| Total Assets | $154,229,000 | $167,594,000 | $159,422,000 | $171,797,000 | $171,615,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,703,000 | 16,195,000 | 8,831,000 | 9,953,000 | 10,688,000 |
| Accounts payable and accrued liabilities | 4,283,000 | 3,887,000 | 4,674,000 | 4,656,000 | 4,536,000 |
| Accrued Expenses | 3,049,000 | 2,390,000 | 2,397,000 | 2,196,000 | 2,487,000 |
| Other current liabilities | 11,561,000 | 9,334,000 | 12,643,000 | 11,115,000 | 11,023,000 |
| TOTAL | $25,920,000 | $37,304,000 | $31,858,000 | $30,427,000 | $31,115,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 37,133,000 | 35,955,000 | 32,909,000 | 33,538,000 | 31,398,000 |
| Deferred Revenues | 1,113,000 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 23,604,000 | 25,208,000 | 27,161,000 | 32,229,000 | 18,478,000 |
| TOTAL | $64,836,000 | $66,844,000 | $63,806,000 | $69,714,000 | $80,660,000 |
| Total Liabilities | $90,756,000 | $104,148,000 | $95,664,000 | $100,141,000 | $111,776,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5,577,630 | 5,547,639 | 5,551,805 | 5,952,865 | 5,951,872 |
| Common Shares | 470,000 | 468,000 | 467,000 | 464,000 | 461,000 |
| Retained earnings | 90,392,000 | 97,670,000 | 89,554,000 | 85,291,000 | 71,774,000 |
| Other shareholders' equity | -5,075,000 | -11,318,000 | -10,906,000 | -8,952,000 | -10,716,000 |
| TOTAL | $63,473,000 | $63,447,000 | $63,758,000 | $71,656,000 | $59,840,000 |
| Total Liabilities And Equity | $154,229,000 | $167,595,000 | $159,422,000 | $171,797,000 | $171,616,000 |